Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • IBM vs MRNA✓SelectedUSD · MRNAIBM vs MRNA performance historyLatest closeAs of-4.71%11/17
Stock and ETF performance explorer

IBM vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+182.3%
MRNA return
+840.0%
Excess return
-657.7%
Maximum drawdown
-39.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-4.7%-3.9%-0.8%-4.6%
7D-5.5%-17.6%+12.1%-5.0%
30D+0.2%-5.1%+5.4%+0.3%
3M+1.7%+220.8%-219.1%-3.2%
6M+6.9%+321.7%-314.8%+0.6%
YTD-19.8%+601.3%-621.1%-26.1%
1Y-20.1%+735.2%-755.3%-26.8%
3Y+65.1%+170.5%-105.5%+54.4%
5Y+135.5%-14.6%+150.1%+123.0%
All+182.3%+840.0%-657.7%+152.8%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling